Ohuma Eric O, Young Melissa F, Martorell Reynaldo, Ismail Leila Cheikh, Peña-Rosas Juan Pablo, Purwar Manorama, Garcia-Casal Maria Nieves, Gravett Michael G, de Onis Mercedes, Wu QingQing, Carvalho Maria, Jaffer Yasmin A, Lambert Ann, Bertino Enrico, Papageorghiou Aris T, Barros Fernando C, Bhutta Zulfiqar A, Kennedy Stephen H, Villar Jose
Maternal, Adolescent, Reproductive and Child Health (MARCH) Centre, London School of Hygiene and Tropical Medicine (LSHTM), London, UK.
Hubert Department of Global Health, Emory University, Atlanta, Georgia.
EClinicalMedicine. 2020 Dec 2;29-30:100660. doi: 10.1016/j.eclinm.2020.100660. eCollection 2020 Dec.
Anaemia in pregnancy is a global health problem with associated morbidity and mortality.
A secondary analysis of prospective, population-based study from 2009 to 2016 to generate maternal haemoglobin normative centiles in uncomplicated pregnancies in women receiving optimal antenatal care. Pregnant women were enrolled <14 weeks' gestation in the Fetal Growth Longitudinal Study (FGLS) of the INTERGROWTH-21 Project which involved eight geographically diverse urban areas in Brazil, China, India, Italy, Kenya, Oman, United Kingdom and United States. At each 5 ± 1 weekly visit until delivery, information was collected about the pregnancy, as well as the results of blood tests taken as part of routine antenatal care that complemented the study's requirements, including haemoglobin values.
A total of 3502 (81%) of 4321 women who delivered a live, singleton newborn with no visible congenital anomalies, contributed at least one haemoglobin value. Median haemoglobin concentrations ranged from 114.6 to 121.4 g/L, 94 to 103 g/L at the 3 centile, and from 135 to 141 g/L at the 97 centile. The lowest values were seen between 31 and 32 weeks' gestation, representing a mean drop of 6.8 g/L compared to 14 weeks' gestation. The percentage variation in maternal haemoglobin within-site was 47% of the total variance compared to 13% between sites.
We have generated International, gestational age-specific, smoothed centiles for maternal haemoglobin concentration compatible with better pregnancy outcomes, as well as adequate neonatal and early childhood morbidity, growth and development up to 2 years of age.
Bill & Melinda Gates Foundation Grant number 49038.
妊娠期贫血是一个全球性的健康问题,伴有相关的发病率和死亡率。
对2009年至2016年基于人群的前瞻性研究进行二次分析,以得出接受最佳产前护理的未合并症孕妇的母体血红蛋白标准百分位数。孕妇在INTERGROWTH-21项目的胎儿生长纵向研究(FGLS)中于妊娠<14周时入组,该项目涉及巴西、中国、印度、意大利、肯尼亚、阿曼、英国和美国的八个地理分布不同的城市地区。在每次妊娠至分娩前5±1周的访视中,收集有关妊娠的信息以及作为常规产前护理一部分进行的血液检查结果,这些检查补充了研究要求,包括血红蛋白值。
4321名分娩活产单胎新生儿且无明显先天性异常的妇女中,共有3502名(81%)至少提供了一个血红蛋白值。血红蛋白浓度中位数在114.6至121.4g/L之间,第3百分位数为94至103g/L,第97百分位数为135至141g/L。最低值出现在妊娠31至32周之间,与妊娠14周相比平均下降6.8g/L。母体内血红蛋白在各研究地点内的变异百分比占总变异的47%,而研究地点之间为13%。
我们已得出与更好的妊娠结局以及新生儿和幼儿至2岁时足够的发病率、生长和发育相匹配的国际、特定孕周、平滑的母体血红蛋白浓度百分位数。
比尔及梅琳达·盖茨基金会,资助编号49038。